Publication | Closed Access
Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.
400
Citations
96
References
2007
Year
NanoparticlesEngineeringLipid NanoparticlesPeptide ScienceBiomedical EngineeringLipid-based Colloidal CarriersProtein NanoparticlesNanomedicineProtein DeliveryDrug Delivery SystemChromatographyVersus Lipid NanoparticlesSolid Lipid NanoparticlesPharmacologyBiomolecular EngineeringBioavailabilityLipid PreparationPharmaceutical NanotechnologyDrug Delivery SystemsNano-drug DeliveryMedicine
Lipid-based colloidal carriers such as liposomes, solid lipid nanoparticles, and nanostructured lipid carriers are increasingly used to deliver therapeutic peptides and proteins orally and parenterally. The study aims to review the pharmaceutical implications of these carriers and to outline strategies for formulating peptides and proteins, assessing association efficiency, and addressing toxicological concerns. It discusses production procedures that achieve high association efficiency by matching physicochemical properties of bioactives and carriers, and evaluates methods for measuring this efficiency while considering toxicological safety. The review reports that such carriers improve bioavailability and produce a more consistent absorption profile for oral delivery, while also highlighting their advantages and drawbacks.
This paper highlights the importance of lipid-based colloidal carriers and their pharmaceutical implications in the delivery of peptides and proteins for oral and parenteral administration. There are several examples of biomacromolecules used nowadays in the therapeutics, which are promising candidates to be delivered by means of liposomes and lipid nanoparticles, such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC). Several production procedures can be applied to achieve a high association efficiency between the bioactives and the carrier, depending on the physicochemical properties of both, as well as on the production procedure applied. Generally, this can lead to improved bioavailability, or in case of oral administration a more consistent temporal profile of absorption from the gastrointestinal tract. Advantages and drawbacks of such colloidal carriers are also pointed out. This article describes strategies used for formulation of peptides and proteins, methods used for assessment of association efficiency and practical considerations regarding the toxicological concerns.
| Year | Citations | |
|---|---|---|
Page 1
Page 1